4//SEC Filing
Krempa David 4
Accession 0001437749-25-000455
CIK 0001710340other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:16 PM ET
Size
7.7 KB
Accession
0001437749-25-000455
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-01-03+38,621→ 38,621 totalExercise: $13.00Exp: 2035-01-02→ Common Stock (38,621 underlying) - Award
Restricted Stock Units
2025-01-03+25,876→ 25,876 total→ Common Stock (25,876 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
- [F2]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001968254
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:16 PM ET
- Size
- 7.7 KB